Sort
30,917 grants matching “tumor microenvironment”
eDyNAmiC (extrachromosomal DNA in Cancer) - Understanding the biology of ecDNA generation and action, and developing new ways to target these mechanisms in cancer
$288,714Andrea Ventura · Sloan-Kettering Inst Can Research · OT2 · FY2025 · CA
Probes targeting multiple myeloma in the context of tumor-stromal interactions
$288,695Douglas McMillin · Axios Biosciences · R43 · FY2013 · CA
Regulation of T cell immunity by stromal cells in autoimmune tissue inflammation
$288,689Viviana Cremasco · Dana-Farber Cancer Inst · P01 · FY2014 · AI
Research Project-Obesity in Cancer: The role of obesity in NF-kB-induced cancer stem cell-like phenotype and its implication in ovarian cancer tumorigenesis and chemoresistance
$288,688Carrie Danielle House · San Diego State University · U54 · FY2020 · MD
Bioinformatics, Biostatistics, and Image Analyses Core
$288,674Xiaole Shirley Liu · Massachusetts General Hospital · P01 · FY2019 · CA
CELL MEDIATED IMMUNITY IN MAMMARY TUMOR MODELS
$288,674University Of Miami School Of Medicine · R01 · FY2003 · CA
Advanced Imaging and Dosimetry Core
$288,672Bryan Patrick Bednarz · University Of Wisconsin-Madison · P01 · FY2023 · CA
Advanced Imaging and Dosimetry Core
$288,672Bryan Patrick Bednarz · University Of Wisconsin-Madison · P01 · FY2022 · CA
Analysis of the Irradiated Tumor and Tumor Microenvironment
$288,587Cristina Montagna · Weill Medical Coll Of Cornell Univ · U54 · FY2024 · CA
Angiogenesis and thalidomide therapy in multiple myeloma
$288,482Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · CA
Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction
$288,477Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2024 · CA
Peroxisome Proliferator-Activated Receptor (gamma) in Lung Cancer
$288,476Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2014 · CA
Heparanase Mechanisms in Brain-metastatic Breast Cancer
$288,430Dario Marchetti · Baylor College Of Medicine · R01 · FY2014 · CA
Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma.
$288,425Sattva S Neelapu · University Of Tx Md Anderson Can Ctr · R21 · FY2010 · CA
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas
$288,391Andreas Friedl · University Of Wisconsin-Madison · R01 · FY2012 · CA
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas
$288,391Andreas Friedl · University Of Wisconsin-Madison · R01 · FY2011 · CA
Paracrine Role of Endothelial Cells on the Colorectal Cancer Stem Cell Phenotype
$288,366Lee M. Ellis · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
B7H1 Mediated Immunosuppression in Glioma
$288,303Orin Bloch · Northwestern University At Chicago · R01 · FY2016 · CA
Increasing the efficacy of MTI-101 in MM using Ab conjugation strategies
$288,301Lori Hazlehurst · Modulation Therapeutics, Inc. · R43 · FY2013 · CA
Flow Cytometry and Technology Development
$288,205Victor M Lemas · Johns Hopkins University · P30 · FY2023 · CA
Flow Cytometry and Technology Development
$288,205Victor M Lemas · Johns Hopkins University · P30 · FY2022 · CA
Flow Cytometry and Technology Development
$288,205Victor M Lemas · Johns Hopkins University · P30 · FY2024 · CA
Multidimensional MRI
$288,150Carl-Fredrik Westin · Brigham And Women'S Hospital · P41 · FY2018 · EB
Aim/Project 1. Dose-response at single-cell and population levels
$288,126Peter Karl Sorger · Harvard Medical School · P50 · FY2015 · GM
Role of Immune Regulatory Pathways in BRAF targeted therapy In melanoma
$288,077Arlene H Sharpe · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA